BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/7/2021 1:41:08 AM | Browse: 444 | Download: 951
 |
Received |
|
2021-01-08 12:27 |
|
Peer-Review Started |
|
2021-01-08 12:29 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-01-25 05:20 |
|
Revised |
|
2021-02-12 14:51 |
|
Second Decision |
|
2021-05-07 07:33 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-05-07 11:57 |
|
Articles in Press |
|
2021-05-07 11:57 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-05-30 08:37 |
|
Publish the Manuscript Online |
|
2021-07-07 01:41 |
| ISSN |
2219-2808 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pediatrics |
| Manuscript Type |
Evidence Review |
| Article Title |
Can omalizumab be used effectively to treat severe conjunctivitis in children with asthma? A case example and review of the literature
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Stephen Doherty, Melissa Mulholland, Michael Shields and Patrick McCrossan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Patrick McCrossan, MBChB, MRCP, Lecturer, Centre of Medical Education, Queens University Belfast, School of Medicine, Dentistry and Biomedical Sciences Whitla Medical Building 97 Lisburn Road
, Belfast BT9 7BL, United Kingdom. p.mccrossan@qub.ac.uk |
| Key Words |
Omalizumab; Conjunctivitis; Allergy; Asthma; Pediatrics; Atopy |
| Core Tip |
Asthma is often associated with multiple atopic conditions which can be more debilitating than the asthma itself. The use of omalizumab has the potential to be effective in the treatment of conjunctivitis associated with asthma and other atopic conditions. However, research is needed to address the question, in the form of multicenter, double-blind randomized control trials. |
| Publish Date |
2021-07-07 01:41 |
| Citation |
Doherty S, Mulholland M, Shields M, McCrossan P. Can omalizumab be used effectively to treat severe conjunctivitis in children with asthma? A case example and review of the literature. World J Clin Pediatr 2021; 10(4): 48-52 |
| URL |
https://www.wjgnet.com/2219-2808/full/v10/i4/48.htm |
| DOI |
https://dx.doi.org/10.5409/wjcp.v10.i4.48 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
